Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 479 |
|
|||||
| News | - | ||||||
| Day High | 0.0007 | Low High |
|||||
| Day Low | 0.0007 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Statera BioPharma Inc (CE) | STAB | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.0007 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.0007 | 0.0007 | 0.0007 | 0.0007 | 0.0007 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5 | 479 | $ 0.0007 | $ 0.3353 | - | 0.000001 - 0.038 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:47:25 | 65 | $ 0.0007 | USD |
Statera BioPharma Inc (CE) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 50.81k | 72.58M | 53.10M | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Statera BioPharma (CE) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical STAB Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.0007 | 0.0007 | 0.0007 | 0.0007 | 1,042 | 0.00 | 0.00% |
| 1 Month | 0.0006 | 0.0007 | 0.0006 | 0.0006654 | 5,505 | 0.0001 | 16.67% |
| 3 Months | 0.0006 | 0.0007 | 0.0003 | 0.0006042 | 29,653 | 0.0001 | 16.67% |
| 6 Months | 0.01 | 0.0103 | 0.000001 | 0.0005272 | 26,210 | -0.0093 | -93.00% |
| 1 Year | 0.0181 | 0.038 | 0.000001 | 0.0169446 | 49,146 | -0.0174 | -96.13% |
| 3 Years | 0.0676 | 0.08 | 0.000001 | 0.0274391 | 218,052 | -0.0669 | -98.96% |
| 5 Years | 0.0676 | 0.08 | 0.000001 | 0.0274391 | 218,052 | -0.0669 | -98.96% |
Statera BioPharma (CE) Description
| Statera Biopharma (formerly Cytocom, Inc.) is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. Statera has one of the largest platforms of toll-like receptor (TLR) agonists in the biopharmaceutical industry with TLR4 and TLR9 antagonists, and the TLR5 agonists, Entolimod and GP532. TLRs are a class of protein that plays a key role in the innate immune system. Statera is developing therapies designed to directly elicit within patients a robust and durable response of antigen-specific killer T-cells and antibodies, thereby activating essential immune defenses against autoimmune, inflammatory, infectious diseases, and cancers. Statera has clinical programs for Crohn's disease (STAT-201), hematology (Entolimod), pancreatic cancer (STAT-401) and COVID-19 (STAT-205) in addition to potential expansion into fibromyalgia and multiple sclerosis. To learn more about Statera Biopharma, please visit www.staterabiopharma.com. |
